MK-4716
/ Merck (MSD)
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 26, 2025
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
(clinicaltrials.gov)
- P1 | N=250 | Not yet recruiting | Sponsor: Merck Sharp & Dohme LLC
Monotherapy • New P1 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1